Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actimmune in Intermediate Osteopetrosis
NCT02666768Phase 2Completed
- Sponsor
- The Lundquist Institute
- Start
- Feb 2016
- Primary completion
- Mar 2019
- Countries
- 1
01
Overview
A Phase 2 trial of interferon gamma-1b in osteopetrosis, sponsored by The Lundquist Institute. Started Feb 2016; status: completed.
02
Drugs
interferon gamma-1b
03
Conditions
osteopetrosis
Beyond the preview
Go deeper on NCT02666768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02666768.